Metagenomi Statistics
Total Valuation
Metagenomi has a market cap or net worth of $62.05 million. The enterprise value is -$119.48 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, after market close.
Earnings Date | May 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Metagenomi has 37.38 million shares outstanding. The number of shares has increased by 372.04% in one year.
Current Share Class | 37.38M |
Shares Outstanding | 37.38M |
Shares Change (YoY) | +372.04% |
Shares Change (QoQ) | -0.77% |
Owned by Insiders (%) | 11.03% |
Owned by Institutions (%) | 24.93% |
Float | 23.31M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.39 |
Forward PS | 2.98 |
PB Ratio | 0.30 |
P/TBV Ratio | 0.29 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.85, with a Debt / Equity ratio of 0.21.
Current Ratio | 5.85 |
Quick Ratio | 5.73 |
Debt / Equity | 0.21 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -31.93% and return on invested capital (ROIC) is -18.87%.
Return on Equity (ROE) | -31.93% |
Return on Assets (ROA) | -15.37% |
Return on Invested Capital (ROIC) | -18.87% |
Return on Capital Employed (ROCE) | -33.99% |
Revenue Per Employee | $224,074 |
Profits Per Employee | -$385,886 |
Employee Count | 202 |
Asset Turnover | 0.13 |
Inventory Turnover | n/a |
Taxes
Income Tax | -5.42M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.86% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -73.86% |
50-Day Moving Average | 1.58 |
200-Day Moving Average | 2.27 |
Relative Strength Index (RSI) | 53.47 |
Average Volume (20 Days) | 296,929 |
Short Selling Information
The latest short interest is 2.40 million, so 6.43% of the outstanding shares have been sold short.
Short Interest | 2.40M |
Short Previous Month | 2.96M |
Short % of Shares Out | 6.43% |
Short % of Float | 10.32% |
Short Ratio (days to cover) | 6.61 |
Income Statement
In the last 12 months, Metagenomi had revenue of $45.26 million and -$77.95 million in losses. Loss per share was -$2.11.
Revenue | 45.26M |
Gross Profit | -57.62M |
Operating Income | -87.69M |
Pretax Income | n/a |
Net Income | -77.95M |
EBITDA | -82.20M |
EBIT | -87.69M |
Loss Per Share | -$2.11 |
Full Income Statement Balance Sheet
The company has $225.97 million in cash and $44.44 million in debt, giving a net cash position of $181.53 million or $4.86 per share.
Cash & Cash Equivalents | 225.97M |
Total Debt | 44.44M |
Net Cash | 181.53M |
Net Cash Per Share | $4.86 |
Equity (Book Value) | 212.66M |
Book Value Per Share | 5.69 |
Working Capital | 193.30M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$102.07 million and capital expenditures -$2.49 million, giving a free cash flow of -$104.55 million.
Operating Cash Flow | -102.07M |
Capital Expenditures | -2.49M |
Free Cash Flow | -104.55M |
FCF Per Share | -$2.80 |
Full Cash Flow Statement Margins
Gross margin is -127.30%, with operating and profit margins of -193.73% and -172.21%.
Gross Margin | -127.30% |
Operating Margin | -193.73% |
Pretax Margin | -184.18% |
Profit Margin | -172.21% |
EBITDA Margin | -181.60% |
EBIT Margin | -193.73% |
FCF Margin | n/a |
Dividends & Yields
Metagenomi does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -372.04% |
Shareholder Yield | -372.04% |
Earnings Yield | -125.62% |
FCF Yield | -168.49% |
Analyst Forecast
The average price target for Metagenomi is $13.00, which is 683.13% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $13.00 |
Price Target Difference | 683.13% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Metagenomi has an Altman Z-Score of -0.21 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.21 |
Piotroski F-Score | 1 |